These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7799026)

  • 1. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
    Lew MA; Kehoe K; Ritz J; Antman KH; Nadler L; Kalish LA; Finberg R
    J Clin Oncol; 1995 Jan; 13(1):239-50. PubMed ID: 7799026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
    Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
    Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
    Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
    Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
    Fox BC; Sollinger HW; Belzer FO; Maki DG
    Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
    Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
    JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.
    Gribble MJ; Puterman ML
    Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
    Gomolin IH; Siami PF; Reuning-Scherer J; Haverstock DC; Heyd A;
    J Am Geriatr Soc; 2001 Dec; 49(12):1606-13. PubMed ID: 11843992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.
    Lew MA; Kehoe K; Ritz J; Antman KH; Nadler L; Takvorian T; Mayer R; Kalish L; Finberg R
    Transplantation; 1991 Mar; 51(3):630-6. PubMed ID: 2006519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
    Gilbert C; Meisenberg B; Vredenburgh J; Ross M; Hussein A; Perfect J; Peters WP
    J Clin Oncol; 1994 May; 12(5):1005-11. PubMed ID: 8164024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial.
    Verdier RI; Fitzgerald DW; Johnson WD; Pape JW
    Ann Intern Med; 2000 Jun; 132(11):885-8. PubMed ID: 10836915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
    Prentice HG; Hann IM; Nazareth B; Paterson P; Bhamra A; Kibbler CC
    Br J Haematol; 2001 Oct; 115(1):46-52. PubMed ID: 11722408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ciprofloxacin combined with sulfamethoxazole-trimethoprim prophylaxis on the incidence of urinary tract infections after kidney transplantation.
    Wojciechowski D; Chandran S
    Transplantation; 2013 Aug; 96(4):400-5. PubMed ID: 23698597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison.
    Grubbs NC; Schultz HJ; Henry NK; Ilstrup DM; Muller SM; Wilson WR
    Mayo Clin Proc; 1992 Dec; 67(12):1163-8. PubMed ID: 1469927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
    De Pauw BE; Donnelly JP; De Witte T; Nováková IR; Schattenberg A
    Bone Marrow Transplant; 1990 Mar; 5(3):179-82. PubMed ID: 2184908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin.
    Nouira S; Marghli S; Besbes L; Boukef R; Daami M; Nciri N; Elatrous S; Abroug F
    Clin Infect Dis; 2010 Jul; 51(2):143-9. PubMed ID: 20536364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
    Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED
    Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal.
    Yeh SP; Hsueh EJ; Yu MS; Wu H; Wang YC
    Bone Marrow Transplant; 1999 Dec; 24(11):1207-11. PubMed ID: 10642810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
    Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
    J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis in blood and marrow transplant recipients.
    Yuen KY; Woo PC
    Hematol Oncol; 2002 Jun; 20(2):51-62. PubMed ID: 12111868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.
    Pizzo PA; Robichaud KJ; Edwards BK; Schumaker C; Kramer BS; Johnson A
    J Pediatr; 1983 Jan; 102(1):125-33. PubMed ID: 6336781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.